224 related articles for article (PubMed ID: 17428505)
1. Potassium bromate treatment predominantly causes large deletions, but not GC>TA transversion in human cells.
Luan Y; Suzuki T; Palanisamy R; Takashima Y; Sakamoto H; Sakuraba M; Koizumi T; Saito M; Matsufuji H; Yamagata K; Yamaguchi T; Hayashi M; Honma M
Mutat Res; 2007 Jun; 619(1-2):113-23. PubMed ID: 17428505
[TBL] [Abstract][Full Text] [Related]
2. Induction of TK mutations in human lymphoblastoid TK6 cells by the rat carcinogen 3-chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX).
Hakulinen P; Yamamoto A; Koyama N; Kumita W; Yasui M; Honma M
Mutat Res; 2011 Oct; 725(1-2):43-9. PubMed ID: 21784170
[TBL] [Abstract][Full Text] [Related]
3. Quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human lymphoblastoid TK6 cells dosed with N-hydroxy-4-acetylaminobiphenyl and their relationship to mutation, toxicity, and gene expression profiling.
Ricicki EM; Luo W; Fan W; Zhao LP; Zarbl H; Vouros P
Anal Chem; 2006 Sep; 78(18):6422-32. PubMed ID: 16970317
[TBL] [Abstract][Full Text] [Related]
4. Possible involvement of oxidative stress in potassium bromate-induced genotoxicity in human HepG2 cells.
Zhang Y; Jiang L; Jiang L; Geng C; Li L; Shao J; Zhong L
Chem Biol Interact; 2011 Feb; 189(3):186-91. PubMed ID: 21182833
[TBL] [Abstract][Full Text] [Related]
5. Anomalous genotoxic responses induced in mouse lymphoma L5178Y cells by potassium bromate.
Priestley CC; Green RM; Fellows MD; Doherty AT; Hodges NJ; O'Donovan MR
Toxicology; 2010 Jan; 267(1-3):45-53. PubMed ID: 19853637
[TBL] [Abstract][Full Text] [Related]
6. Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the thymidine kinase gene-mutation assay and the in vitro modified comet assay: determination of No-Observed-Genotoxic-Effect-Levels.
Platel A; Nesslany F; Gervais V; Claude N; Marzin D
Mutat Res; 2011 Dec; 726(2):151-9. PubMed ID: 21930235
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of loss of heterozygosity induced by vinblastine at tk locus in human lymphoblastoid cell line TK6].
Wang YN; Shuai PQ; Guo YJ; Zhang LS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):558-61. PubMed ID: 16909601
[TBL] [Abstract][Full Text] [Related]
8. Generation of loss of heterozygosity and its dependency on p53 status in human lymphoblastoid cells.
Honma M
Environ Mol Mutagen; 2005; 45(2-3):162-76. PubMed ID: 15688360
[TBL] [Abstract][Full Text] [Related]
9. Mutagenic radioadaptation in a human lymphoblastoid cell line.
Yatagai F; Umebayashi Y; Honma M; Sugasawa K; Takayama Y; Hanaoka F
Mutat Res; 2008 Feb; 638(1-2):48-55. PubMed ID: 17919664
[TBL] [Abstract][Full Text] [Related]
10. Study of oxidative DNA damage in TK6 human lymphoblastoid cells by use of the in vitro micronucleus test: Determination of No-Observed-Effect Levels.
Platel A; Nesslany F; Gervais V; Marzin D
Mutat Res; 2009 Aug; 678(1):30-7. PubMed ID: 19559100
[TBL] [Abstract][Full Text] [Related]
11. Bromate induces loss of heterozygosity in the thymidine kinase gene of L5178Y/Tk(+/-)-3.7.2C mouse lymphoma cells.
Harrington-Brock K; Collard DD; Chen T
Mutat Res; 2003 May; 537(1):21-8. PubMed ID: 12742504
[TBL] [Abstract][Full Text] [Related]
12. Biological significance of DNA adducts: comparison of increments over background for various biomarkers of genotoxicity in L5178Y tk(+/-) mouse lymphoma cells treated with hydrogen peroxide and cumene hydroperoxide.
Brink A; Richter I; Lutz U; Wanek P; Stopper H; Lutz WK
Mutat Res; 2009 Aug; 678(2):123-8. PubMed ID: 19539047
[TBL] [Abstract][Full Text] [Related]
13. Tests for genotoxicity and mutagenicity of furan and its metabolite cis-2-butene-1,4-dial in L5178Y tk+/- mouse lymphoma cells.
Kellert M; Brink A; Richter I; Schlatter J; Lutz WK
Mutat Res; 2008 Dec; 657(2):127-32. PubMed ID: 18804178
[TBL] [Abstract][Full Text] [Related]
14. [Loss of heterozygosity induced by cyclophosphamide at tk locus in human lymphoblastoid cell line TK6].
Zhan L; Zhang LS; Wang L; Zhang H; Takayoshi S; Masamitsu H; Wu DS
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):334-7. PubMed ID: 15931861
[TBL] [Abstract][Full Text] [Related]
15. Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling.
Le Fevre AC; Boitier E; Marchandeau JP; Sarasin A; Thybaud V
Mutat Res; 2007 Jun; 619(1-2):16-29. PubMed ID: 17374387
[TBL] [Abstract][Full Text] [Related]
16. Potassium diazoacetate-induced p53 mutations in vitro in relation to formation of O6-carboxymethyl- and O6-methyl-2'-deoxyguanosine DNA adducts: relevance for gastrointestinal cancer.
Gottschalg E; Scott GB; Burns PA; Shuker DE
Carcinogenesis; 2007 Feb; 28(2):356-62. PubMed ID: 16926174
[TBL] [Abstract][Full Text] [Related]
17. Possible participation of oxidative stress in causation of cell proliferation and in vivo mutagenicity in kidneys of gpt delta rats treated with potassium bromate.
Umemura T; Tasaki M; Kijima A; Okamura T; Inoue T; Ishii Y; Suzuki Y; Masui N; Nohmi T; Nishikawa A
Toxicology; 2009 Mar; 257(1-2):46-52. PubMed ID: 19133310
[TBL] [Abstract][Full Text] [Related]
18. The DNA-damaging potential of tamoxifen in breast cancer and normal cells.
Wozniak K; Kolacinska A; Blasinska-Morawiec M; Morawiec-Bajda A; Morawiec Z; Zadrozny M; Blasiak J
Arch Toxicol; 2007 Jul; 81(7):519-27. PubMed ID: 17593413
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional responses to ionizing radiation reveal that p53R2 protects against radiation-induced mutagenesis in human lymphoblastoid cells.
Tsai MH; Chen X; Chandramouli GV; Chen Y; Yan H; Zhao S; Keng P; Liber HL; Coleman CN; Mitchell JB; Chuang EY
Oncogene; 2006 Jan; 25(4):622-32. PubMed ID: 16247478
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro micronucleus and gene mutation assay results for p53-competent versus p53-deficient human lymphoblastoid cells.
Honma M; Hayashi M
Environ Mol Mutagen; 2011 Jun; 52(5):373-84. PubMed ID: 20963812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
